CircRNA-002178 enriched in lung cancer-derived EVs upregulates PD-L1 and PD-1 expression in cancer cells and CD8 + T cells, respectively, leading to increased T cell exhaustion and diminished tumor clearance [95]. The gene discussed is CD8A; the disease is lung carcinoma.